United States · Biopharma startup

Harmony Biosciences

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Funding reportedLast round: Post ipo debt

BiopharmaPlymouth Meeting, United States

What company datasets say Harmony Biosciences raised

Funding, as reported

Reported in all$1.4Bin dollars
Rounds8
Last roundPost ipo debt
Last round dateJul 2023
Investors listed11

Founders and team

From Harmony Biosciences's own website: 1 founder, 9 on the team.

Jeffrey S. AroninHarmony Founder and Non-Executive Chairman
  • Cate McCanlessSenior Vice President and Chief Corporate Affairs Officer
  • Harmony BiosciencesPresident and Chief Executive Officer
  • Orbital TherapeuticsChief Executive Officer
  • Ron PhilipPresident and Chief Executive Officer
  • Audrey MurphyChief Human Resources Officer
  • Peter AnastasiouChief Operating Officer
  • Tricia GloverChief Compliance Officer
  • Troy IgnelziChief Financial Officer
  • Juan SabaterPartner

On 2 portfolio pages

Investors who name them

Each firm lists Harmony Biosciences on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biopharma in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Harmony Biosciences in front of investors. Or tell us what we have wrong.

List your startupSend a correction